La-Z-Boy (LZB) Tops Q2 EPS by 10c, Offers Guidance
Tweet
Share
E-mail
Get Alerts LZB Hot Sheet
Price: $41.06 --0%
Revenue Growth %: +0.7%
Financial Fact:
Income tax expense (benefit): 11.9M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Revenue Growth %: +0.7%
Financial Fact:
Income tax expense (benefit): 11.9M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
La-Z-Boy (NYSE: LZB) reported Q2 EPS of $0.74, $0.10 better than the analyst estimate of $0.64. Revenue for the quarter came in at $511 million versus the consensus estimate of $502.55 million.
GUIDANCE:
La-Z-Boy sees Q3 2024 revenue of $515-535 million, versus the consensus of $533 million.
For earnings history and earnings-related data on La-Z-Boy (LZB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
